As of 2025-12-29, the Relative Valuation of Cannara Biotech Inc (LOVE.CN) is (0.34) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.12 CAD, the upside of Cannara Biotech Inc based on Relative Valuation is -381.2%.
The range of the Relative Valuation is (0.34) - (0.36) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.9x - 20.3x | 18.1x |
| Forward P/E multiples | 18.2x - 19.6x | 18.9x |
| Fair Price | (0.34) - (0.36) | (0.34) |
| Upside | -380.2% - -402.4% | -381.2% |
| Date | P/E |